Featured Research

from universities, journals, and other organizations

Long-term use of Parkinson's drug may impact vision

Date:
June 4, 2010
Source:
American Academy of Ophthalmology
Summary:
Parkinson's disease, the second most common neurodegenerative disease after Alzheimer's, is often treated with amantadine. The drug helps alleviate patients' motor problems and may be taken for years. Doctors have long known that amantadine treatment causes abnormal changes in the cornea in some Parkinson's patients. The cornea is the eye's clear outer surface that provides most of the visual power. Usually corneal reactions occur soon after starting the drug and disappear a few weeks after it is withdrawn. But sometimes corneal disorders appear only after years of treatment, and the corneas of these patients often do not recover when amantadine is stopped.

Parkinson's disease, the second most common neurodegenerative disease after Alzheimer's, is often treated with amantadine. The drug helps alleviate patients' motor problems and may be taken for years. Doctors have long known that amantadine treatment causes abnormal changes in the cornea in some Parkinson's patients. The cornea is the eye's clear outer surface that provides most of the visual power. Usually corneal reactions occur soon after starting the drug and disappear a few weeks after it is withdrawn. But sometimes corneal disorders appear only after years of treatment, and the corneas of these patients often do not recover when amantadine is stopped.

Won Ryang Wee, MD, PhD, and his colleagues at Seoul National University College of Medicine, South Korea, studied whether the effect of amandatine on corneal endothelial cells is dependent on the cumulative dose received.

The researchers compared 169 eyes of amandatine-treated patients with an equal number of matched controls; the average age of all subjects was 59. They found that the patient group with the highest cumulative amandatine intake and/or longest duration of treatment (up to 8 years) had the most significant reductions in endothelial cell density (ECD). Endothelial cells work to keep excess water out of the main body of the cornea. When there are too few endothelial cells, corneal edema (swelling) results and vision is impaired. This study noted two early indicators of abnormal corneal changes in response to amandatine, before ECD reduction occurred: deformation of the normal hexagonal cell shape, and increase in cell size variation. The findings also show that ECD reduction in response to amandatine treatment does not occur quickly.

"Assuming other studies confirm these results, ophthalmologists and neurologists should consider evaluating a patient's corneal endothelium at the beginning of treatment with amandatine and reassess at regular intervals if the drug is used long term," Dr. Wee said, "and additional monitoring would be needed for patients with other conditions that reduce ECD-such as recent cataract surgery or ongoing glaucoma, uveitis or Fuch's dystrophy-because corneal edema could develop during treatment."


Story Source:

The above story is based on materials provided by American Academy of Ophthalmology. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ki Cheol Chang, Jin Ho Jeong, Mee Kum Kim, Won Ryang Wee, Jin Hak Lee, Beom Seok Jeon. The Effect of Amantadine on Corneal Endothelium in Subjects with Parkinson's Disease. Ophthalmology, 2010; DOI: 10.1016/j.ophtha.2009.10.039

Cite This Page:

American Academy of Ophthalmology. "Long-term use of Parkinson's drug may impact vision." ScienceDaily. ScienceDaily, 4 June 2010. <www.sciencedaily.com/releases/2010/06/100601114629.htm>.
American Academy of Ophthalmology. (2010, June 4). Long-term use of Parkinson's drug may impact vision. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2010/06/100601114629.htm
American Academy of Ophthalmology. "Long-term use of Parkinson's drug may impact vision." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601114629.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Liberia Pleads for Help to Fight Ebola

Liberia Pleads for Help to Fight Ebola

AP (Sep. 22, 2014) Liberia's finance minister is urging the international community to quickly follow through on pledges of cash to battle Ebola. Bodies are piling up in the capital Monrovia as the nation awaits more help. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Ebola Doctor Says Border Controls Critical

Ebola Doctor Says Border Controls Critical

AP (Sep. 22, 2014) A Florida doctor who helped fight the expanding Ebola outbreak in West Africa says the disease can be stopped, but only if nations quickly step up their response and make border control a priority. (Sept. 22) Video provided by AP
Powered by NewsLook.com
Global Ebola Aid Increasing But Critics Say It's Late

Global Ebola Aid Increasing But Critics Say It's Late

Newsy (Sep. 21, 2014) More than 100 tons of medical supplies were sent to West Africa on Saturday, but aid workers say the global response is still sluggish. Video provided by Newsy
Powered by NewsLook.com
Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins